drugset / Trial / NCT04799002
Topotecan and Melphalan for Retinoblastoma
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate topotecan and melphalan for retinoblastoma patients.
Timeline
- Start
- 2021-03-11
- Primary completion
- 2024-12-30
- Completion
- 2027-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Melphalan | Small molecule | — | Other |
| Comparator | Topotecan | Small molecule | — | Other |